Percutaneous Coronary Intervention
PCI utilization decreased but rebounded quickly during pandemic
Registry data revealed large decreases in the utilization of PCI during the COVID‐19 pandemic, which rebounded quickly by mid-2021.
Social deprivation index may predict outcomes after PCI
High social deprivation index as a marker of lower socioeconomic resources is associated with increased risk for recurrent hospitalization for congestive heart failure and death after PCI, researchers reported.
Same-day discharge safe after chronic total occlusion PCI for select patients
Registry data show same-day discharge after PCI cases for chronic total occlusion is safe in select patients, has been increasing over time and is strongly associated with radial‐only access, researchers reported.
3-month DAPT noninferior to 12-month after PCI using third-generation stents
NEW ORLEANS — An all-comers trial excluding patients with STEMI showed that after PCI, 3-month dual antiplatelet therapy was noninferior to 12-month DAPT for the composite outcome of net adverse clinical events, a speaker reported.
FDA designates intra-aortic balloon pump recall as class I
The FDA announced it has designated a recall of intra-aortic balloon pumps by Datascope/Getinge as class I, the most serious kind.
Target vessel failure reduced after intravascular imaging- vs. angiography-guided PCI
NEW ORLEANS — Intravascular imaging-guided PCI was associated with lower risk for target vessel failure vs. angiography-guided PCI for the treatment of complex coronary artery lesions, a speaker reported.
Study questions prognostic value of myocardial viability in patient selection for PCI
NEW ORLEANS — PCI may not improve survival or left ventricular recovery among patients with ischemic cardiomyopathy compared with optimal medical therapy alone, regardless of baseline myocardial viability, a speaker reported.
On-site FFR-CT using machine learning reduces invasive procedures in stable CAD
NEW ORLEANS — In patients with stable CAD, use of CT-derived fractional flow reserve with on-site machine learning reduced invasive coronary angiography in those who did not need it, but did not improve other outcomes, researchers reported.
Intracoronary epinephrine may best IV delivery for in-hospital cardiac arrest
Intracoronary epinephrine improved survival, return of spontaneous circulation and neurological outcomes vs. IV epinephrine for cardiac arrest during cardiac catheterization, researchers reported.
CABG outperforms PCI in multivessel disease in real-world cohort with ACS
In a real-world cohort of Medicare beneficiaries with ACS and multivessel CAD, CABG conferred lower odds of mortality, readmission and repeat procedures compared with PCI, researchers reported.